{"id":11331,"date":"2022-07-01T20:33:33","date_gmt":"2022-07-02T00:33:33","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/a-look-ahead-cancer-immunotherapy-breakthroughs-on-the-horizon\/"},"modified":"2022-07-14T16:05:56","modified_gmt":"2022-07-14T20:05:56","slug":"a-look-ahead-cancer-immunotherapy-breakthroughs","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs","title":{"rendered":"A Look Ahead: Cancer Immunotherapy Breakthroughs on the Horizon"},"content":{"rendered":"<p style=\"text-align: center;\"><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/GIiK09A5DEI\" width=\"640\"><\/iframe><\/p>\n<p>On January&nbsp;15, 2017, noted cancer immunotherapy expert Jedd D. Wolchok, MD, PhD explored the latest developments in the field across a variety of cancers, including melanoma, lung cancer, head and neck cancer, bladder cancer, and hodgkin lymphoma, and look ahead to the anticipated clinical trial data readouts in 2017.&nbsp;Cancer immunotherapy is one of the most promising new approaches to treating cancer patients today.&nbsp;<\/p>\n<p>Dr. Wolchok is chief of the Melanoma and Immunotherapeutics Service and director of the Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center (MSKCC); an associate director of the Ludwig Center for Cancer Immunotherapy at MSKCC, an associate member of Ludwig Cancer Research, and the Lloyd J. Old\/Virginia and Daniel K. Ludwig Chair in Clinical Investigation at MSKCC. He is director of the CRI\/Ludwig Clinical Trials Network, and is an associate director of the Cancer Research Institute Scientific Advisory Council.<\/p>\n<p>This webinar is part of the Cancer Research Institute&#39;s webinar series, &quot;Cancer Immunotherapy and You,&quot; which are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&amp;A. This series is presented by Bristol-Myers Squibb and Genentech. For more information on this webinar, or to register for upcoming webinars, please visit <a href=\"https:\/\/www.cancerresearch.org\/webinars\" target=\"_blank\" rel=\"noopener\">www.cancerresearch.org\/webinars<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Jedd D. Wolchok of Memorial Sloan Kettering explores&nbsp;the latest developments in the field across a variety of cancers, including melanoma, lung cancer, head and neck cancer, bladder cancer, and hodgkin lymphoma, and looks ahead to the anticipated clinical trial data readouts in 2017.<\/p>\n","protected":false},"featured_media":4281,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11331","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2017: Cancer Immunotherapy Breakthroughs on the Horizon<\/title>\n<meta name=\"description\" content=\"Dr. Jedd D. Wolchok of Memorial Sloan Kettering explores\u00a0the latest developments in the field and looks ahead to the anticipated clinical trial data readouts in 2017.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2017: Cancer Immunotherapy Breakthroughs on the Horizon\" \/>\n<meta property=\"og:description\" content=\"Dr. Jedd D. Wolchok of Memorial Sloan Kettering explores\u00a0the latest developments in the field and looks ahead to the anticipated clinical trial data readouts in 2017.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:05:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7ad53343-35a1-49a3-9b4b-251043d40073.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"2017: Cancer Immunotherapy Breakthroughs on the Horizon\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Jedd D. Wolchok of Memorial Sloan Kettering explores\u00a0the latest developments in the field and looks ahead to the anticipated clinical trial data readouts in 2017.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7ad53343-35a1-49a3-9b4b-251043d40073.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs\",\"name\":\"2017: Cancer Immunotherapy Breakthroughs on the Horizon\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/bbcaf86b-68cb-441e-9c68-a243df3fe633.jpg\",\"datePublished\":\"2022-07-02T00:33:33+00:00\",\"dateModified\":\"2022-07-14T20:05:56+00:00\",\"description\":\"Dr. Jedd D. Wolchok of Memorial Sloan Kettering explores\u00a0the latest developments in the field and looks ahead to the anticipated clinical trial data readouts in 2017.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/bbcaf86b-68cb-441e-9c68-a243df3fe633.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/bbcaf86b-68cb-441e-9c68-a243df3fe633.jpg\",\"width\":440,\"height\":440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"A Look Ahead: Cancer Immunotherapy Breakthroughs on the Horizon\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2017: Cancer Immunotherapy Breakthroughs on the Horizon","description":"Dr. Jedd D. Wolchok of Memorial Sloan Kettering explores\u00a0the latest developments in the field and looks ahead to the anticipated clinical trial data readouts in 2017.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs","og_locale":"es_ES","og_type":"article","og_title":"2017: Cancer Immunotherapy Breakthroughs on the Horizon","og_description":"Dr. Jedd D. Wolchok of Memorial Sloan Kettering explores\u00a0the latest developments in the field and looks ahead to the anticipated clinical trial data readouts in 2017.","og_url":"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:05:56+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7ad53343-35a1-49a3-9b4b-251043d40073.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"2017: Cancer Immunotherapy Breakthroughs on the Horizon","twitter_description":"Dr. Jedd D. Wolchok of Memorial Sloan Kettering explores\u00a0the latest developments in the field and looks ahead to the anticipated clinical trial data readouts in 2017.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7ad53343-35a1-49a3-9b4b-251043d40073.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs","url":"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs","name":"2017: Cancer Immunotherapy Breakthroughs on the Horizon","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/bbcaf86b-68cb-441e-9c68-a243df3fe633.jpg","datePublished":"2022-07-02T00:33:33+00:00","dateModified":"2022-07-14T20:05:56+00:00","description":"Dr. Jedd D. Wolchok of Memorial Sloan Kettering explores\u00a0the latest developments in the field and looks ahead to the anticipated clinical trial data readouts in 2017.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/bbcaf86b-68cb-441e-9c68-a243df3fe633.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/bbcaf86b-68cb-441e-9c68-a243df3fe633.jpg","width":440,"height":440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/a-look-ahead-cancer-immunotherapy-breakthroughs#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"A Look Ahead: Cancer Immunotherapy Breakthroughs on the Horizon"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/4281"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11331"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11331"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11331"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11331"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11331"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11331"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}